Physician profile
Jad Daye
NPI 1043503907
$8,684.36
in general payments reported to CMS, 2019-2025
47 companies · $818 in 2025
The $818 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $859 · 2021: $798 · 2022: $1,875 · 2023: $1,608 · 2024: $1,610 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,035.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,007.78 | 2019-2021 | |
| Abbott Laboratories | $695.26 | 2019-2025 | Xience Skypoint, Cardiomems, Jot Dx |
| Amgen INC. | $655.80 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $650.92 | 2022-2025 | Venaseal, Hawkone |
| Philips North America LLC | $556.10 | 2023-2024 | (Bh4) Igt Devices Undivided, (5153) Azurion 5 M20 Gc |
| Shockwave Medical, INC | $545.96 | 2022 | |
| Janssen Pharmaceuticals, INC | $455.01 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $335.97 | 2019-2023 | Watchman Flx, Watchman, Watchman Access System |
| Merck Sharp & Dohme LLC | $335.83 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $301.68 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $256.97 | 2019-2025 | |
| Penumbra, INC. | $239.64 | 2024 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.86 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $224.83 | 2019-2025 | Wainua, Farxiga |
| Inari Medical, INC. | $187.32 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $160.69 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $156.83 | 2019-2024 | Rotarexs 6 F X 135 Cm |
| Edwards Lifesciences Corporation | $146.67 | 2023 | |
| Biotronik INC. | $133.59 | 2019-2023 | Orsiro Mission |
| Heartflow, INC. | $130.99 | 2024 | |
| Glaxosmithkline, LLC. | $129.87 | 2020-2025 | Arexvy, Shingrix |
| Actelion Pharmaceuticals US, INC. | $113.27 | 2024-2025 | Uptravi, Opsumit |
| Atricure, INC. | $106.39 | 2022 | |
| Pfizer INC. | $102.86 | 2019-2025 | |
| Esperion Therapeutics, INC. | $97.02 | 2021-2023 | Nexletol |
| Kestra Medical Technology Services, INC. | $96.80 | 2025 | Assure Wcd |
| Angiodynamics, INC. | $76.58 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Biosense Webster, INC. | $67.90 | 2024 | Carto 3 |
| Lundbeck LLC | $66.75 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.86 | 2021-2025 | Jardiance |
| Imperative Care, INC | $29.78 | 2025 | Symphony Catheter |
| Tactile Systems Technology INC | $29.67 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Impulse Dynamics (USA) INC. | $29.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.71 | 2021-2022 | |
| Cvrx, INC. | $25.98 | 2023 | Barostim Neo System |
| Agepha Pharma Fz LLC | $24.40 | 2025 | Lodoco |
| Scpharmaceuticals INC. | $24.23 | 2025 | |
| Astellas Pharma US INC | $21.95 | 2020 | |
| Medicomp INC | $21.86 | 2021 | |
| Cleerly, INC. | $18.98 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Azurity Pharmaceuticals, INC. | $18.85 | 2023 | Edarbi |
| Cordis US Corp. | $17.21 | 2024 | Angioguard |
| Teleflex LLC | $16.72 | 2023 | Turnpike |
| Lexicon Pharmaceuticals, INC. | $14.87 | 2024 | |
| Preventice Services, LLC | $14.36 | 2021 | |
| Cashflow Solutions, LLC | $13.13 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jad Daye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.